全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Pleomorphic Lobular Carcinoma in a Male Breast: A Rare Occurrence

DOI: 10.4061/2010/871369

Full-Text   Cite this paper   Add to My Lib

Abstract:

Carcinoma of male breast is uncommon as it accounts for 0.7% of total breast cancer. The pathology of male breast cancer is remarkably similar to that of cancers seen in women. The same histological subtypes of invasive cancer are present, although papillary carcinomas (both invasive and in situ) are more common and lobular carcinomas are less common. The predominant histological type, in males, as in females, reported in large series has been infiltrating ductal carcinoma with scattered reports of infiltrating lobular carcinoma, all of them of classical type except for a single case of pleomorphic infiltrating lobular carcinoma. Herein, we describe a case of pleomorphic lobular carcinoma occurring in male breast. 1. Introduction Carcinoma arising in the male breast is a rare occurrence. The overall incidence in men is only 1% of that in women, which translates to a lifetime risk of 0.11% (as compared with about 13% in women). Risk factors are similar to those in women and include first-degree relatives with breast cancer, decreased testicular function (e.g., Klinefelter syndrome), exposure to exogenous estrogens, increasing age, infertility, obesity, prior benign breast disease, exposure to ionizing radiation, and residency in Western countries. Gynecomastia does not seem to be a risk factor. From 4% to 14% of cases in males are attributed to germline BRCA2 mutations. Male breast cancer accounts for 0.7% of total breast cancer [1]. Over the past 25 years, the incidence of male breast cancer has risen by 26%, from 0.86 to 1.08 per 100,000 population [2]. Approximately 85% of primary male breast carcinoma is invasive ductal carcinoma of the “no special type” subtype [3]. Carcinomas of the male breast grossly and microscopically are remarkably similar to those seen in females [4]. The predominant histological type, in males, reported in large series has been infiltrating ductal carcinoma with scattered reports of infiltrating lobular carcinoma [5], all of them were classical type except for single case of pleomorphic infiltrating lobular carcinoma [6]. 2. Case Report 2.1. Clinical Details A 55-year-old male presented with left breast mass of approximately five-month duration. There was no history of trauma, gynaecomastia, oestrogen administration, or drug use. Physical examination revealed a subareolar mass measuring 4 × 4?cm in size. Swelling was firm to hard and nontender. Overlying skin was free. There was no palpable axillary lymph node. Lumpectomy of the breast mass was done. 2.2. Pathological Findings On macroscopic examination, the specimen

References

[1]  I. A. Jaiyesimi, A. U. Buzdar, A. A. Sahin, and M. A. Ross, “Carcinoma of the male breast,” Annals of Internal Medicine, vol. 117, no. 9, pp. 771–777, 1992.
[2]  S. H. Giordano, “A review of the diagnosis and management of male breast cancer,” Oncologist, vol. 10, no. 7, pp. 471–479, 2005.
[3]  P. K. Chantra, M. S. Shiroshi, G. J. So, J. S. Wollman, and L. W. Bassett, in Diagnosis of Diseases of the Breast, L. W. Bassett, V. P. Jackson, K. L. Fu, and Y. S. Fu, Eds., pp. 531–556, Saunders, Philadelphia, Pa, USA, 2nd edition, 2005.
[4]  W. L. Donegan, “Cancer of the breast in men,” CA: A Cancer Journal for Clinicians, vol. 41, no. 6, pp. 339–354, 1991.
[5]  P. E. Goss, C. Reid, M. Pintilie, R. Lim, and N. Miller, “Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955–1996,” Cancer, vol. 85, no. 3, pp. 629–639, 1999.
[6]  B. Maly, A. Maly, I. Pappo, K. Meir, and O. Pappo, “Pleomorphic variant of invasive lobular carcinoma of the male breast,” Virchows Archiv, vol. 446, no. 3, pp. 344–345, 2005.
[7]  S. Ferlicot, A. Vincent-Salomon, J. Médioni et al., “Wide metastatic spreading in infiltrating lobular carcinoma of the breast,” European Journal of Cancer, vol. 40, no. 3, pp. 336–341, 2004.
[8]  N. Weidner and J. P. Semple, “Pleomorphic variant of invasive lobular carcinoma of the breast,” Human Pathology, vol. 23, no. 10, pp. 1167–1171, 1992.
[9]  A. Wahed, J. Connelly, and T. Reese, “E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma,” Annals of Diagnostic Pathology, vol. 6, no. 6, pp. 349–351, 2002.
[10]  J. Palacios, D. Sarrió, M. C. García-Macias, B. Bryant, M. E. Sobel, and M. J. Merino, “Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast,” Modern Pathology, vol. 16, no. 7, pp. 674–678, 2003.
[11]  Y.-Y. Chen, E.-S. S. Hwang, R. Roy et al., “Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast,” American Journal of Surgical Pathology, vol. 33, no. 11, pp. 1683–1694, 2009.
[12]  G. Turashvili, K. Bouchalova, J. Bouchal, and Z. Kolar, “Expression of E-cadherin and c-erbB-2/HER-2/neu oncoprotein in high-grade breast cancer,” Ceskoslovenská Patologie, vol. 43, no. 3, pp. 87–92, 2007.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133